Zobrazeno 1 - 10
of 12
pro vyhledávání: '"D. Gonzalez Vaquero"'
Autor:
D Gonzalez Vaquero, C Redondo Galán, M Ferris Villanueva, M. D. Rivas Rodríguez, JF Rangel Mayoral
Publikováno v:
Section 5: Patient safety and quality assurance.
Background and importance Tocilizumab is an immunosuppressive agent which has demonstrated high efficacy in clinical trials for the treatment of coronavirus because its mechanism of action seems to inhibit the inflammatory cascade Aim and objectives
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89a82f64175303074b93cc013006a904
https://doi.org/10.1136/ejhpharm-2021-eahpconf.291
https://doi.org/10.1136/ejhpharm-2021-eahpconf.291
Autor:
C Redondo Galán, R Medina Comas, Rivas Rodríguez, M Ferris Villanueva, D Gonzalez Vaquero, JF Rangel Mayoral
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance With the arrival of the global SARS-CoV-2 pandemic, hospital pharmacy services (HPS) have had to adapt to emerging needs. One of these measures has been the sending of medicines to vulnerable patients who, due to their patho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ac46d11fdd81c773bc7e373f1974ffc
https://doi.org/10.1136/ejhpharm-2021-eahpconf.220
https://doi.org/10.1136/ejhpharm-2021-eahpconf.220
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance The roles of hospital pharmacists have been expanded from dispensing to patient care. Establishing interprofessional collaboration between pharmacists and other specialists significantly improves the quality of patient care.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc348bb7aaa0eb2b1d70ac4157003fe8
https://doi.org/10.1136/ejhpharm-2021-eahpconf.205
https://doi.org/10.1136/ejhpharm-2021-eahpconf.205
Autor:
P Acosta Robles, A Martos Rosa, D Gonzalez Vaquero, J Urda Romacho, M Aznar Garcia, F Avila Cabrera, MA Castro Vida
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Malaria is a parasitic disease caused by the parasite Plasmodium falciparum that is transmitted through the bite of infected Anopheles female mosquitoes. It is a deadly disease that requires diagnosis and urgent treatment. The treatment is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::259a03c7b22ffd5308f9e628eced7571
https://doi.org/10.1136/ejhpharm-2019-eahpconf.204
https://doi.org/10.1136/ejhpharm-2019-eahpconf.204
Autor:
A Martos Rosa, P Acosta Robles, J Urda Romacho, D Gonzalez Vaquero, G Gómiz Rodriguez, E Manzano López
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background Rituximab is a monoclonal antibody indicated in Spain in adults with non-Hodgkin’s lymphoma, chronic lymphatic leukaemia, rheumatoid arthritis and granulomatosis with polyangiitis and microscopic polyangiitis. Purpose To evaluate the use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1aabb83db8a9b3ef39dfedcdae1c840
https://doi.org/10.1136/ejhpharm-2019-eahpconf.563
https://doi.org/10.1136/ejhpharm-2019-eahpconf.563
Autor:
JA Morales Molina, P Acosta Robles, A Martos Rosa, M Aznar Garcia, JE Martinez De La Plata, D Gonzalez Vaquero, F Avila Cabrera
Publikováno v:
Eur J Hosp Pharm
Background Cutaneous diphtheria is a skin infection caused by toxigenic and non-toxigenic strains of Corynebacterium diphtheriae. It is characterised by chronic nonhealing ulcers. Diagnosis may be delayed because it is a rare infection in developed c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24512d7451a2a1dc53b5152618f72db9
https://doi.org/10.1136/ejhpharm-2018-eahpconf.311
https://doi.org/10.1136/ejhpharm-2018-eahpconf.311
Autor:
J Urda Romacho, P Acosta Robles, A Martos Rosa, M Aznar Garcia, D Gonzalez Vaquero, A Jofre Peralta, JA Morales Molina, MACastro Vida, JE Martinez De La Plata, F Avila Cabrera
Publikováno v:
Eur J Hosp Pharm
Background Darunavir/cobicistat (DRV/COB) is the first fixed combination inhibitor of protease. Both are metabolised by the cytochrome CYP3A4, the reason why they are susceptible to present a multitude of drug interactions (DI). Purpose To describe t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb1dd3db1aea1aff4e15a0e519ee799c
https://doi.org/10.1136/ejhpharm-2018-eahpconf.402
https://doi.org/10.1136/ejhpharm-2018-eahpconf.402
Autor:
JB Montoro Ronsano, R. Albertos Martell, D. Berlana, S Garcia Garcia, R. Burgos Peláez, P. Sanchez-Sancho, C. Puiggros, D. Gonzalez Vaquero, I. Cardona Pascual
Publikováno v:
Clinical Nutrition. 38:S63-S64
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e9601ac028f6e70b90e69a7ed3566f0
https://doi.org/10.1016/s0261-5614(19)32651-2
https://doi.org/10.1016/s0261-5614(19)32651-2
Autor:
D Gonzalez Vaquero, JM Fernández Martín, MA Castro Vida, José Antonio Morales-Molina, J Urda Romacho, P Acosta Robles
Publikováno v:
European Journal of Hospital Pharmacy. 23:A178.3-A179
Background Determination of the plasma concentration of free phenytoin (C p FL) could improve seizure control and prevent adverse effects. Purpose To evaluate the safety profile of patients treated with phenytoin using C p FL. Material and methods Pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d58d86dbf08bfdaf8437609689d59c0f
https://doi.org/10.1136/ejhpharm-2016-000875.405
https://doi.org/10.1136/ejhpharm-2016-000875.405
Autor:
JM Fernández Martín, D Gonzalez Vaquero, A Martos Rosa, M Gimeno Jordá, JA Morales Molina, J Urda Romacho, A Fayet Pérez
Publikováno v:
European Journal of Hospital Pharmacy. 22:A81.3-A82
Background Rilpivirine/Emtricitabine/Tenofovir (RPV/FTC/TDF) is a single tablet regimen recommended for treatment-naive HIV patients with baseline viral load (VL) 1 Purpose To analyse the usage profile, effectiveness and safety of RPV/FTC/TDF. Materi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8bf39736b9c70372b318848762d490f3
https://doi.org/10.1136/ejhpharm-2015-000639.195
https://doi.org/10.1136/ejhpharm-2015-000639.195